Why did Tesla’s robotaxi attract federal regulators?
How will Iran's threats impact global oil prices?
Why is the US House banning WhatsApp on devices?
What caused Kroger to announce 60 store closures?
How did US strikes on Iran affect stock markets?
Why is the UK committing to 5% defense spending?
How is Goldman Sachs using generative AI firmwide?
Pops as Weight-Loss Drug Data from Rival Novo Nordisk Disappoints
tipranks.com/news/eli-lilly-stock-lly-pops-as-weight-loss-drug-data-from-rival-novo-nordisk-disappoints
Eli Lilly’s (LLY) stock is marching higher on news that rival Novo Nordisk (NVO) has issued data on its newest weight-loss drug candidate that disappointed.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment…
This story appeared on tipranks.com, 2025-06-23 21:49:26.966000.